Mirena IUD on menstrual patterns in patients with adenomyosis and sexual quality of life in clinical research

Qiong Fu, Hong Li, Lu Chen, Bing-shu Li, Min Hu
In: Zhongguo yishi zazhi · 2011 · vol. 13(04) , pp. 451–453 · doi:10.3760/cma.j.issn.1008-1372.2011.04.006 · W2590954981
Non-randomised trial OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Mirena IUD use in 56 adenomyosis patients reduced dysmenorrhea and menstrual quantity after 3 months, with sexual function improving after 6 months.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-30 · read from full text ⓘ

This clinical study evaluated the impact of the Mirena intrauterine device on menstrual patterns and sexual quality of life in 56 women diagnosed with adenomyosis. Researchers tracked patients over a twelve-month period, utilizing specific scoring methods for dysmenorrhea and menstrual blood loss alongside the Brief Index of Sexual Function for Women to assess changes at one, three, six, nine, and twelve months post-insertion. The results indicated that while initial improvements were not significant at one month, pain levels and menstrual volume decreased substantially by three to twelve months, with comprehensive sexual function metrics showing marked improvement after six months of treatment. This paper is centrally about adenomyosis — specifically examining the therapeutic efficacy of levonorgestrel-releasing intrauterine systems on symptom management and sexual health outcomes in affected patients.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objective To investigate the effect on the menstrual patterns and sexual quality of life of patients with adenomyosis after treated with Mirena IUD.Methods 56 patients with adenomyosis who were treated with Mirena IUD were recruited from August 2009 to December 2009.We used Menstrual blood loss chart method,Dysmenorrhea score method and Brief Index of Sexual Function for Women (BISF-W) to evaluate the menstrual pattern,the volume of uterus and sexual quality after1,3,6,9,12 months.{Results 53 patients were followed up,the rate was 94.6%.The condition of 56 patients became better after treated with Mirena for 3,6,9,12 months,dysmenorrhea[Placed before:(3.15±0.91)points;After placing:(1.41±0.51)points,(0.22±0.09)points,(0.07±0.01)points,0 points]and menstrual quantity[Placed before:(12.0±57.5)points;After placing:(71±23.1)points,(29±19.4)points,(18±10.5)points,(10±4.7)points]were both reduced(P＜0.05),the symptoms were not significantly improved after 1 month(P＞0.05).D2 indicators was significantly improved after 3 months of treatment (P＜0.05),sexual function was also improved after 6 months(P＜0.05～0.01).Conclusions Mirena IUD has a good effect on the menstrual pattern and sexual function for patients with adenomyosis. Key words: Intrauterine devices/AE; Uterine diseases; Adenomyoma; Menstruation; Coitus
Full text 1,931 characters · extracted from oa-doi-fallback · click to expand
曼月乐节育环对子宫腺肌病患者月经模式和性生活质量影响的临床研究 Mirena IUD on menstrual patterns in patients with adenomyosis and sexual quality of life in clinical research 摘要目的 探讨曼月乐节育环治疗子宫腺肌病后对患者的月经模式和性生活质量的影响.方法 选择2009年8月至2009年12月子宫腺肌病放置曼月乐节育环的患者56例,采用月经失血图法,痛经评分法,国际女性性功能评估量表评价患者治疗前、治疗后1、3、6、9、12个月月经模式、子宫体积和性功能情况.结果 53例患者顺利完成随访,随访率94.6%.56例子宫腺肌病患者在放置曼月乐环后3、6、9、12个月痛经程度较放置曼月乐前减轻[放置前:(3.15±0.91)分;放置后:(1.41±0.51)分,(0.22±0.09)分,(0.07±0.01)分,0分,P＜0.05)],月经量减少[放置前:(12.0±57.5)分;放置后:(71±23.1)分,(29±19.4)分,(18±10.5)分,(10±4.7)分,P＜0.05];治疗1个月性功能各项指标均无明显改善(P＞0.05),治疗3个月后仅D2指标有明显改善(P＜0.05),治疗6个月后性功能各项指标均有改善(P＜0.05～0.01).结论 曼月乐节育环对子宫腺肌病患者的月经模式和性功能恢复疗效好. 更多相关知识 abstractsObjective To investigate the effect on the menstrual patterns and sexual quality of life of patients with adenomyosis after treated with Mirena IUD.Methods 56 patients with adenomyosis who were treated with Mirena IUD were recruited from August 2009 to December 2009.We used Menstrual blood loss chart method,Dysmenorrhea score method and Brief Index of Sexual Function for Women (BISF-W) to evaluate the menstrual pattern,the volume of uterus and sexual quality after1,3,6,9,12 months.{Results 53 patients were followed up,the rate was 94.6%.The condition of 56 patients became better after treated with Mirena for 3,6,9,12 months,dysmenorrhea[Placed before:(3.15±0.91)points;After placing:(1.41±0.51)points,(0.22±0.09)points,(0.07±0.01)points,0 points]and menstrual quantity[Placed before:(12.0±57.5)points;After placing:(71±23.1)points,(29±19.4)points,(18±10.5)points,(10±4.7)points]were both reduced(P＜0.05),the symptoms were not significantly improved after 1 month(P＞0.05).D2 indicators was significantly improved after 3 months of treatment (P＜0.05),sexual function was also improved after 6 months(P＜0.05～0.01).Conclusions Mirena IUD has a good effect on the menstrual pattern and sexual function for patients with adenomyosis. More相关知识 - 浏览0 - 被引27 - 下载0 相似文献 - 中文期刊 - 外文期刊 - 学位论文 - 会议论文

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosisdysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK